Universal Health Services (UHS) opened Q1 2026 with total revenue of US$4.5 billion, basic EPS of US$5.71 and net income of US$348.7 million, setting a clear marker for how the year is starting. The company has seen quarterly revenue move from US$4.1 billion and EPS of US$4.87 in Q1 2025 to US$4.5 billion and EPS of US$5.71 in Q1 2026. Trailing twelve month EPS reached US$24.29 on revenue of US$17.8 billion. With net profit margins running at 8.6% over the last year, the latest results give investors fresh numbers to test how durable those margins look heading into the rest of 2026.

See our full analysis for Universal Health Services.

With the headline figures on the table, the next step is to see how these earnings stack up against the widely held narratives around Universal Health Services, highlighting where the story matches expectations and where it starts to look different.

27.1% earnings growth meets cautious forecasts

• Over the last 12 months, earnings grew 27.1% and net profit margin moved from 7.4% to 8.6% on US$17.8b of revenue, pointing to stronger profitability in the trailing period than the single Q1 snapshot alone shows.
• What bullish investors highlight is that this profit momentum, combined with plans to open 10 to 15 new outpatient behavioral facilities each year, could support revenue and EBITDA growth. However, the data set shows analysts expect earnings to edge down by about 0.2% per year over the next three years, which directly challenges the idea of an earnings acceleration.
  • The bullish view leans on expanding behavioral health capacity and technology investments to support long term growth, while the current forecast effectively keeps earnings flat to slightly lower despite the 27.1% trailing increase.
  • This gap between strong trailing numbers and modest forward expectations is a key area for you to weigh when thinking about how durable that recent margin move to 8.6% might be.

Bulls argue the latest margin improvement and behavioral buildout could keep pushing profits higher, while forecasts remain conservative about where earnings go from here, so it helps to see how that debate is set out in full in the 🐂 Universal Health Services Bull Case.

Low 6.5x P/E versus peers and a high DCF value

• The shares trade on a P/E of 6.5x compared with peer and industry averages of 22x and 24.6x, and the DCF fair value in this data is US$550.39 against a current share price of US$162.54. Taken together, these figures describe a large gap between price and these valuation references.
• Consensus narrative points to revenue growth of 5.7% per year and margins easing from 8.6% to 7.5%, which helps explain why the analyst price target of US$243.82 is well below the DCF fair value but still above the current price, leaving you with a mix of signals rather than a single clear read from the valuation metrics.
  • The low P/E ratio and the DCF fair value of US$550.39 both sit far above the share price, while the US$243.82 analyst target reflects more moderate assumptions about earnings holding around US$1.5b.
  • This combination suggests the trailing profitability and current pricing are being weighed against expectations for slightly lower future margins and slower revenue growth than the broader US market.

High debt and policy risks weigh on the bear case

• The company carries a high level of debt and earnings are forecast to decline by about 0.2% per year over the next three years, aligning with concerns that heavier leverage plus slower earnings could constrain financial flexibility even after US$1.5b of net income over the last 12 months.
• Bears focus on the combination of high debt and the expected US$360 million to US$400 million annual hit to Medicaid supplemental payments by 2032. However, the same data set shows 27.1% trailing earnings growth and a margin move to 8.6%, which means recent performance has not yet reflected those longer term pressures.
  • The cautious narrative leans on lower reimbursement and wage pressures when explaining the small projected earnings decline, whereas the trailing period captured stronger profitability before those policy changes fully phase in.
  • For you, the key question is how much weight to place on the improved recent margin against the combination of leverage and future Medicaid changes that are already highlighted in the risk section.

Skeptics warn that elevated debt and future Medicaid payment cuts could matter more than the strong trailing numbers, so it is worth reading the detailed cautious case set out in the 🐻 Universal Health Services Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Universal Health Services on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both optimism around recent margins and concern about future headwinds in play, it makes sense to move quickly and look through the figures yourself. You can start with the 4 key rewards and 2 important warning signs.

See What Else Is Out There

For all the strong trailing margins, the combination of high debt, cautious earnings forecasts and future Medicaid headwinds leaves real questions about resilience.

If that mix of leverage and policy risk feels uncomfortable, use the 1 resilient stocks with low risk scores to quickly find companies where balance sheets and risk scores may feel more reassuring.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.